- Home
- CDTX vs ACTG Comparison
CDTX vs ACTG Comparison
Compare CDTX & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- ACTG
- Stock Information
- Founded
- CDTX 2012
- ACTG 1993
- Country
- CDTX United States
- ACTG United States
- Employees
- CDTX N/A
- ACTG N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- ACTG Multi-Sector Companies
- Sector
- CDTX Health Care
- ACTG Miscellaneous
- Exchange
- CDTX Nasdaq
- ACTG Nasdaq
- Market Cap
- CDTX 333.3M
- ACTG 363.5M
- IPO Year
- CDTX 2015
- ACTG 1996
- Fundamental
- Price
- CDTX $21.68
- ACTG $3.73
- Analyst Decision
- CDTX Strong Buy
- ACTG
- Analyst Count
- CDTX 8
- ACTG 0
- Target Price
- CDTX $41.17
- ACTG N/A
- AVG Volume (30 Days)
- CDTX 157.5K
- ACTG 263.8K
- Earning Date
- CDTX 05-08-2025
- ACTG 05-08-2025
- Dividend Yield
- CDTX N/A
- ACTG N/A
- EPS Growth
- CDTX N/A
- ACTG N/A
- EPS
- CDTX N/A
- ACTG N/A
- Revenue
- CDTX $302,000.00
- ACTG $222,414,000.00
- Revenue This Year
- CDTX N/A
- ACTG $141.36
- Revenue Next Year
- CDTX N/A
- ACTG N/A
- P/E Ratio
- CDTX N/A
- ACTG N/A
- Revenue Growth
- CDTX N/A
- ACTG 65.22
- 52 Week Low
- CDTX $10.14
- ACTG $2.70
- 52 Week High
- CDTX $28.42
- ACTG $5.74
- Technical
- Relative Strength Index (RSI)
- CDTX 47.21
- ACTG 57.69
- Support Level
- CDTX $18.91
- ACTG $3.58
- Resistance Level
- CDTX $24.91
- ACTG $3.87
- Average True Range (ATR)
- CDTX 1.86
- ACTG 0.13
- MACD
- CDTX -0.18
- ACTG 0.00
- Stochastic Oscillator
- CDTX 33.41
- ACTG 36.59
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.